J. Goldman & Co LP - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 110 filers reported holding ATHIRA PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2022$1,552,000
+10.1%
114,950
+6.2%
0.07%
-9.0%
Q4 2021$1,410,000108,2000.08%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$57,938,0008.52%
ACUTA CAPITAL PARTNERS, LLC 393,000$13,460,0003.66%
Logos Global Management LP 947,873$32,465,0002.78%
RTW INVESTMENTS, LP 2,685,779$88,899,0001.49%
Avidity Partners Management LP 1,043,873$35,753,0001.16%
Perceptive Advisors 3,114,805$106,682,0001.14%
Sofinnova Investments, Inc. 509,168$17,439,0001.04%
HighVista Strategies LLC 32,062$1,098,0000.70%
Rock Springs Capital Management LP 860,902$29,486,0000.62%
PFM Health Sciences, LP 470,227$16,105,0000.57%
View complete list of ATHIRA PHARMA INC shareholders